Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

FHTX

FHTX News

Newswire

10:41

Platform Technologies Fuel $211B Surge in Precision Cancer Treatment: GT Biopharma, Erasca, Foghorn, OmniAb, and Recursion Pharmaceuticals Poised to Capture Growth in the $212B U.S. Oncology Market

10:28

Oncology sector shifts toward precision therapies, US market projected to surge to $212 bln by 2034.

12:01

Stifel Initiates Coverage on Buy, PT $12: Foghorn

07:03

Foghorn Therapeutics to Present at 8th Annual Evercore Healthcare Conference

11:18

Foghorn shares surge 20.26% intraday as H.C. Wainwright analyst reiterates Buy rating with $13 price target.

View More

About FHTX

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More